Search research articles
Contact Us
Filters
Showing results (191-200 of 224) with videos related to
Page
of 23
Sort By:
Journal of Cellular Physiology
|
January 12, 2018
Haplo-insufficiency of Bcl2-associated athanogene 3 in mice results in progressive left ventricular dysfunction, β-adrenergic insensitivity, and increased apoptosis
Valerie D Myers, Dhanendra Tomar, Muniswamy Madesh, et al.
Clinical and Translational Science
|
October 27, 2010
Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study
William T Abraham, Juan M Aranda, John P Boehmer, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 5, 2013
The second member of transient receptor potential-melastatin channel family protects hearts from ischemia-reperfusion injury
Barbara A Miller, JuFang Wang, Iwona Hirschler-Laszkiewicz, et al.
Circulation
|
June 21, 2013
Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction
Neelakantan T Vasudevan, Maradumane L Mohan, Manveen K Gupta, et al.
JCI Insight
|
November 25, 2016
Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury
Feifei Su, Valerie D Myers, Tijana Knezevic, et al.
Circulation
|
February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial
Inder S Anand, Peter Carson, Elizabeth Galle, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 6, 2010
Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity
Eman A Hamad, Xue Li, Jianliang Song, et al.
American Heart Journal
|
June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004
Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of Molecular and Cellular Cardiology
|
January 23, 2016
BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes
Arthur M Feldman, Jennifer Gordon, JuFang Wang, et al.
Clinical and Translational Science
|
April 1, 2010
Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor
Tung O Chan, Hajime Funakoshi, Jianliang Song, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 224) with videos related to
Sort By:
Page
of 23
Journal of Cellular Physiology
|
January 12, 2018
Haplo-insufficiency of Bcl2-associated athanogene 3 in mice results in progressive left ventricular dysfunction, β-adrenergic insensitivity, and increased apoptosis
Valerie D Myers, Dhanendra Tomar, Muniswamy Madesh, et al.
Clinical and Translational Science
|
October 27, 2010
Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study
William T Abraham, Juan M Aranda, John P Boehmer, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 5, 2013
The second member of transient receptor potential-melastatin channel family protects hearts from ischemia-reperfusion injury
Barbara A Miller, JuFang Wang, Iwona Hirschler-Laszkiewicz, et al.
Circulation
|
June 21, 2013
Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction
Neelakantan T Vasudevan, Maradumane L Mohan, Manveen K Gupta, et al.
JCI Insight
|
November 25, 2016
Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury
Feifei Su, Valerie D Myers, Tijana Knezevic, et al.
Circulation
|
February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial
Inder S Anand, Peter Carson, Elizabeth Galle, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 6, 2010
Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity
Eman A Hamad, Xue Li, Jianliang Song, et al.
American Heart Journal
|
June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004
Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of Molecular and Cellular Cardiology
|
January 23, 2016
BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes
Arthur M Feldman, Jennifer Gordon, JuFang Wang, et al.
Clinical and Translational Science
|
April 1, 2010
Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor
Tung O Chan, Hajime Funakoshi, Jianliang Song, et al.
Page
of 23